Insider Move From SEC: Todd Kingma just Sold 750 shares of Perrigo Company plc Ordinary Shares (NYSE:PRGO), be careful if you are long!

November 23, 2016 - By Ellis Scott

Insider Move From SEC: Todd Kingma just Sold 750 shares of Perrigo Company plc Ordinary Shares (NYSE:PRGO), be careful if you are long!

Todd Kingma Insider Sell

In a public form which was filled with the DC-based SEC, it was stated that the Executive VP – General Counsel of Perrigo Co Plc Todd Kingma, an insider in focus, made sale through a broker for 750 shares of the stock exchange listed company, having a total value of $66,512 USD using an average price per share of $88.7 USD. At present, he holds 16,560 shares or 0.01% of the company’s total market capitalization.

Perrigo Company plc Ordinary Shares (NYSE:PRGO) Ratings Coverage

Out of 15 analysts covering Perrigo Company Plc (NYSE:PRGO), 4 rate it a “Buy”, 1 “Sell”, while 10 “Hold”. This means 27% are positive. $241 is the highest target while $84 is the lowest. The $128.45 average target is 44.07% above today’s ($89.16) stock price. Perrigo Company Plc has been the topic of 35 analyst reports since October 23, 2015 according to StockzIntelligence Inc. On Monday, April 25 the stock rating was downgraded by Wells Fargo to “Market Perform”. The firm has “Buy” rating by Deutsche Bank given on Thursday, August 11. JP Morgan maintained it with “Neutral” rating and $90 target price in Thursday, August 11 report. The firm has “Neutral” rating by B. Riley & Co given on Friday, November 11. The stock of Perrigo Company plc Ordinary Shares (NYSE:PRGO) earned “Overweight” rating by Barclays Capital on Thursday, January 21. The firm has “Outperform” rating by Northland Capital given on Tuesday, December 22. As per Wednesday, April 6, the company rating was maintained by Argus Research. The firm earned “Neutral” rating on Wednesday, November 18 by JP Morgan. The firm earned “Neutral” rating on Monday, April 25 by BTIG Research. Bank of America upgraded Perrigo Company plc Ordinary Shares (NYSE:PRGO) on Friday, November 11 to “Neutral” rating.

Insitutional Activity: The institutional sentiment decreased to 0.77 in 2016 Q2. Its down 0.04, from 0.81 in 2016Q1. The ratio is negative, as 102 funds sold all Perrigo Company plc Ordinary Shares shares owned while 173 reduced positions. 80 funds bought stakes while 142 increased positions. They now own 86.20 million shares or 12.38% less from 98.38 million shares in 2016Q1.

The Wisconsin-based North Star Asset Mgmt has invested 1.08% in Perrigo Company plc Ordinary Shares (NYSE:PRGO). Pacific Glob Management accumulated 7,790 shares or 0.16% of the stock. Continental Advsrs Ltd last reported 0.39% of its portfolio in the stock. Intl Grp owns 61,083 shares or 0% of their US portfolio. The Illinois-based Gofen Glossberg Ltd Liability Il has invested 0.16% in Perrigo Company plc Ordinary Shares (NYSE:PRGO). Amica Mutual Insurance holds 0.09% or 10,272 shares in its portfolio. Eagle Asset Mngmt, a Florida-based fund reported 17,893 shares. Ig Limited has invested 0.03% of its portfolio in Perrigo Company plc Ordinary Shares (NYSE:PRGO). Envestnet Asset Mgmt has 0.01% invested in the company for 27,625 shares. Aviva Public Ltd Limited Liability Company owns 80,842 shares or 0.05% of their US portfolio. Winslow Evans And Crocker last reported 0% of its portfolio in the stock. Moreover, Swiss National Bank has 0.06% invested in Perrigo Company plc Ordinary Shares (NYSE:PRGO) for 401,462 shares. Tci Wealth holds 0% or 13 shares in its portfolio. Quinn Opportunity Prtnrs Ltd Company last reported 0.38% of its portfolio in the stock. British Columbia Investment Corp holds 69,285 shares or 0.06% of its portfolio.

Insider Transactions: Since August 26, 2016, the stock had 1 buying transaction, and 6 selling transactions for $1.08 million net activity. Another trade for 2,500 shares valued at $221,875 was made by Parker Geoffrey M. on Monday, November 21. 2,095 Perrigo Company plc Ordinary Shares (NYSE:PRGO) shares with value of $184,947 were sold by Brown Judy L. MORRIS HERMAN JR sold 1,073 shares worth $97,595. Shares for $107,404 were sold by Farrington Thomas on Monday, September 26. KUNKLE GARY K JR sold $522,974 worth of stock or 5,814 shares.

About 491,830 shares traded hands. Perrigo Company plc Ordinary Shares (NYSE:PRGO) has declined 31.74% since April 21, 2016 and is downtrending. It has underperformed by 37.07% the S&P500.

According to Zacks Investment Research, “Perrigo Company plc develops, manufactures and distributes healthcare products. The company operates primarily in four segments: Consumer Healthcare, Nutritionals, Rx Pharmaceutical and Active Pharmaceutical Ingredients. It also provides animal health products. The company operates primarily in the United States, the United Kingdom, Mexico, Israel, Australia, Canada, China and Latin America. Perrigo Company plc formerly known as Perrigo Company is headquartered in Ireland.”

Analysts await Perrigo Company plc Ordinary Shares (NYSE:PRGO) to report earnings on February, 16. They expect $1.67 earnings per share, down 7.22% or $0.13 from last year’s $1.8 per share. PRGO’s profit will be $235.82M for 13.35 P/E if the $1.67 EPS becomes a reality. After $1.65 actual earnings per share reported by Perrigo Company plc Ordinary Shares for the previous quarter, Wall Street now forecasts 1.21% EPS growth.

More recent Perrigo Company plc Ordinary Shares (NYSE:PRGO) news were published by: Fool.com which released: “Why Perrigo Company PLC Ordinary Shares Are Dropping Today” on April 25, 2016. Also Fool.com published the news titled: “Why Perrigo Company PLC Ordinary Shares Are Plummeting Today” on February 18, 2016. Investorplace.com‘s news article titled: “3 Stocks to Watch Monday: Tesla Motors Inc (TSLA), Perrigo Company plc ..” with publication date: September 12, 2016 was also an interesting one.

PRGO Company Profile

Perrigo Company plc (Perrigo), formerly Perrigo Company Limited, incorporated on June 28, 2013, is an over-the-counter (OTC) consumer goods and specialty pharmaceutical company. The Company’s divisions include Consumer Healthcare (CHC), Branded Consumer Healthcare (BCH), Prescription Pharmaceuticals (Rx), Specialty Sciences and Other. The Firm makes OTC healthcare products and supplies infant formulas for the store brand market. It is also a well-known provider of generic extended topical prescription products. It provides healthcare products across a range of product categories and geographies, primarily in North America, Europe and Australia, as well as in other markets, including Israel and China.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Tags: , ,

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Market News

>